UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Methadone and naltrexone in heroin addiction--an explanation from the SBU

Läkartidningen, 2002-02, Vol.99 (6), p.552

2002

Link zum Volltext

Verfügbarkeit prüfen

Documented effect of methadone, but not naltrexone

Läkartidningen, 2002-02, Vol.99 (6), p.551

Heilig, Markus

2002

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

American Journal of Psychiatry, 2018-12, Vol.175 (12), p.1205-1215

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10118), p.309-318

2018

Link zum Volltext

Verfügbarkeit prüfen

Bupropion and Naltrexone in Methamphetamine Use Disorder

The New England journal of medicine, 2021-01, Vol.384 (2), p.140-153

2021

Link zum Volltext

Verfügbarkeit prüfen

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Drug and alcohol dependence, 2019-07, Vol.200, p.34-39

2019

Link zum Volltext

Verfügbarkeit prüfen

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

The New England journal of medicine, 2016-03, Vol.374 (13), p.1232-1242

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Journal of controlled release, 2017-06, Vol.255, p.27-35

2017

Link zum Volltext

Verfügbarkeit prüfen

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Addiction (Abingdon, England), 2018-07, Vol.113 (7), p.1188-1209

2018

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Human Natural Killer Cells by Different Classes of Opioids

Anesthesia and analgesia, 2019-05, Vol.128 (5), p.1013-1021

2019

Link zum Volltext

Verfügbarkeit prüfen

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

Obesity (Silver Spring, Md.), 2011-01, Vol.19 (1), p.110-120

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029

2013

Link zum Volltext

Verfügbarkeit prüfen

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

Biological psychiatry (1969), 2013-04, Vol.73 (8), p.706-713

2013

Link zum Volltext

Verfügbarkeit prüfen

Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes

Neuropsychopharmacology (New York, N.Y.), 2018-03, Vol.43 (4), p.891-899

2018

Link zum Volltext

Verfügbarkeit prüfen

Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

Addiction (Abingdon, England), 2013-09, Vol.108 (9), p.1628-1637

2013

Link zum Volltext

Verfügbarkeit prüfen

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

The Lancet (British edition), 2011, Vol.377 (9776), p.1506-1513

2011

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

The American journal of psychiatry, 2019-02, Vol.176 (2), p.129-137

2019

Link zum Volltext

Verfügbarkeit prüfen

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

The Journal of pharmacology and experimental therapeutics, 2019-11, Vol.371 (2), p.409

2019

Link zum Volltext

Verfügbarkeit prüfen

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment

The American journal of psychiatry, 2021-07, Vol.178 (7), p.660-671

2021

Link zum Volltext

Verfügbarkeit prüfen

Placebo analgesia and its opioidergic regulation suggest that empathy for pain is grounded in self pain

Proceedings of the National Academy of Sciences - PNAS, 2015-10, Vol.112 (41), p.E5638-E5646

2015

Link zum Volltext

Verfügbarkeit prüfen

Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls

Mayo Clinic proceedings, 2020-09, Vol.95 (9), p.1964-1977

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer

Journal of clinical oncology, 2017-12, Vol.35 (34), p.3859-3866

2017

Link zum Volltext

Verfügbarkeit prüfen

Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys

Psychopharmacology, 2020-05, Vol.237 (5), p.1471-1480

2020

Link zum Volltext

Verfügbarkeit prüfen

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2015-05, Vol.72 (5), p.430

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Annals of oncology, 2016-11, Vol.27 (11), p.2032-2038

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.415

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.184)
Mit Volltextzugriff
(1.913)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.984)
Life Sciences & Biomedicine
(1.949)
Male
(1.582)
Naltrexone - Administration & Dosage
(1.417)
Animals
(1.234)
Humans
(1.172)
Naltrexone - Pharmacology
(966)
Narcotic Antagonists - Administration & Dosage
(898)
Naltrexone
(871)
Female
(851)
Biological And Medical Sciences
(815)
Pharmacology & Pharmacy
(807)
Medical Sciences
(688)
Naltrexone - Analogs & Derivatives
(680)
Rats
(662)
Adult
(610)
Narcotic Antagonists - Pharmacology
(601)
Dose-Response Relationship, Drug
(572)
Neurosciences & Neurology
(569)
Naltrexone - Therapeutic Use
(555)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Methadone and naltrexone in heroin addiction--an explanation from the SBU

Documented effect of methadone, but not naltrexone

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Bupropion and Naltrexone in Methamphetamine Use Disorder

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Suppression of Human Natural Killer Cells by Different Classes of Opioids

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes

Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment

Placebo analgesia and its opioidergic regulation suggest that empathy for pain is grounded in self pain

Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls

Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer

Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Suchergebnisse filtern